News & Updates

Show Multimedia Only

Healthy living in early adulthood may prevent steatotic liver disease in midlife

Maintaining a healthy lifestyle or making lifestyle changes in early adulthood helps reduce the risk of developing steatotic liver disease in midlife, even for individuals with genetic predisposition, as shown in a study.

Healthy living in early adulthood may prevent steatotic liver disease in midlife

a day ago

COVID-19 vaccination provides consistent protection for pregnant women

09 Feb 2026 by

Getting a COVID-19 shot prior to or during pregnancy reduces the risks of severe maternal disease outcomes and preterm birth, and this protection remains consistent across different variant periods, according to a study from Canada.

COVID-19 vaccination provides consistent protection for pregnant women

09 Feb 2026

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

09 Feb 2026

Treatment with the novel natriuretic peptide receptor-1 (NPR-1) agonist XXB750 demonstrates a neutral effect on 24-h ambulatory systolic blood pressure (SBP) in patients with resistant hypertension, as shown by the results of a phase II trial.

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

09 Feb 2026

Asthma patients in SG show poor inhaler adherence, good disease control

09 Feb 2026 by

Adherence to inhaler therapy among adult asthma patients in Singapore is intermediate or poor, reports a study, noting the importance of targeted interventions.

Asthma patients in SG show poor inhaler adherence, good disease control

09 Feb 2026

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

09 Feb 2026

Quality of life (QOL) among patients with systemic lupus erythematosus (SLE) improves following CD19 chimeric antigen receptor (CAR) T cell therapy, with also helps lessen the socioeconomic burden associated with active disease, a study has shown.

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

09 Feb 2026

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

09 Feb 2026 by

A systematic review and meta-analysis conducted by researchers in Singapore support ceftazidime-avibactam (CAZ/AVI) as a primary therapeutic alternative for the treatment of OXA-48–producing carbapenem-resistant Enterobacterales (CRE).

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

09 Feb 2026

Lead exposure may put children at risk of depression

09 Feb 2026

Low-levels blood lead concentrations in children are associated with the presence of depressive symptoms in later childhood, according to a study.

Lead exposure may put children at risk of depression

09 Feb 2026

Nortriptyline misses mark in functional dyspepsia trial

08 Feb 2026

The tricyclic antidepressant nortriptyline is only as good as placebo in terms of reducing symptoms of functional dyspepsia in preselected patients, according to the results of a multicentre randomized controlled trial.

Nortriptyline misses mark in functional dyspepsia trial

08 Feb 2026

Low SBP does not raise risk of all-cause mortality, CV events

08 Feb 2026

Blood pressure (BP) shows a linear association with several cardiovascular (CV) and renal outcomes in patients with type 2 diabetes (T2D), reveals a study.

Low SBP does not raise risk of all-cause mortality, CV events

08 Feb 2026

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC

08 Feb 2026

Treatment with the combination of savolitinib plus osimertinib prolongs progression-free survival (PFS) in patients with non-small cell lung cancer (NSCLC) harbouring EGFR mutation and MET amplification, as shown in the phase III SACHI trial.

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC

08 Feb 2026

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Healthy living in early adulthood may prevent steatotic liver disease in midlife

Healthy living in early adulthood may prevent steatotic liver disease in midlife

COVID-19 vaccination provides consistent protection for pregnant women

COVID-19 vaccination provides consistent protection for pregnant women

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

Novel NPR-1 agonist no better than placebo for treatment of resistant hypertension

Asthma patients in SG show poor inhaler adherence, good disease control

Asthma patients in SG show poor inhaler adherence, good disease control

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

CD19 CAR T cell therapy improves QOL, cuts healthcare costs in SLE

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

Meta-analysis supports CAZ/AVI as Tx option for OXA-48–producing CRE

Lead exposure may put children at risk of depression

Lead exposure may put children at risk of depression

Nortriptyline misses mark in functional dyspepsia trial

Nortriptyline misses mark in functional dyspepsia trial

Low SBP does not raise risk of all-cause mortality, CV events

Low SBP does not raise risk of all-cause mortality, CV events

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC

PFS gains seen with savolitinib–osimertinib combo in EGFR-mutant, MET-amplified NSCLC